For patients with XDR tuberculosis, the overall risk-benefit ratio seems to favor patients receiving the bedaquiline-pretomanid-linezolid regimen with linezolid at a dose of 600 mg for 26 weeks.
An artificial intelligence system can detect pulmonary tuberculosis (TB) on chest X-rays with a higher sensitivity than radiologists.
Researchers assessed the safety and effectiveness of twice-daily dolutegravir dosing plus rifampicin in children with HIV-associated tuberculosis infection.
Should clofazimine remain a “second-choice agent” for treating patients with multidrug-resistant tuberculosis? A meta-analysis reviews the current evidence.
Researchers assessed treatment outcomes among women with multidrug-resistant tuberculosis infection during pregnancy.
Researchers assessed the diagnostic accuracy of nanopore sequencing for the early identification of pulmonary tuberculosis.
Researchers assessed the safety and efficacy of repeat bacille Calmette-Guérin vaccination among adults during the convalescent period of COVID-19 infection.
New research re-examines the current concern that using moxifloxacin in the shorter regimen for drug-resistant TB might increase the risk for QT prolongation.
A systemic review looked at the effect of diabetes on plasma concentrations and the bioavailability of rifampicin in patients with tuberculosis.
In this meta-analysis, researchers assessed the relationship between cytomegalovirus and the risk for incident tuberculosis infection.
